Table 1.
Clinical characteristics of participants
| Characteristics | T2D patients (n = 31) | Healthy donors (n = 18) |
|---|---|---|
| Female, n (%) | 18 (58.1) | 10 (55.6) |
| Age, years (range) | 57 (37–75) | 52 (30–68) |
| BMI (kg/m2) | 24.96 ± 0.65 | 22.34 ± 0.81 |
| HbA1c (%) | 8.92 ± 0.31 | 5.25 ± 0.98 |
| FPG (mmol/L) | 9.80 ± 0.56 | 4.18 ± 0.78 |
| Insulin (μIU/mL) | 30.31 ± 8.04 | 10.82 ± 5.09 |
| Diabetes duration (years) | 13.45 ± 1.66 | – |
| Total lymphocytes (%) | 32.91 ± 1.90 | 35.01 ± 2.30 |
| Total monocytes (%) | 5.25 ± 0.33 | 4.99 ± 0.36 |
| CD4+ T cells (%) | 35.92 ± 2.35 | 33.95 ± 2.44 |
| CD8+ T cells (%) | 32.10 ± 1.45 | 34.26 ± 2.38 |
| CD14+ monocytes (%) | 72.21 ± 2.37 | 73.86 ± 3.50 |
Data are expressed as median ± standard error of the mean. BMI, body mass index; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; T2D, type 2 diabetes.